Discover
Pharma Digest
39 Episodes
Reverse
Lilly pays $6.3B upfront for sleep disorder-focused Centessa in latest neuroscience playAmbrosia scores $100M series B to take next-gen oral GLP-1 into the clinicMerck enlists antibody hunter Infinimmune for $838M biobucks pact
Mapping the Trillion-Gene Universe: The Startup That Wants to Teach AI the Language of LifeWhy Data Infrastructure Determines AI Success in Drug DiscoveryPhenoTips, Health Institutions Launch C$5.4M AI Genomic Medicine Initiative in Canada
AstraZeneca delivers dream result as phase 3 COPD hits breathe life into class rocked by flopsLilly further embraces Insilico’s AI tech, inking R&D collab worth up to $2.75BMerck dives into detailed phase 3 data showing PCSK9 pill easily outswims rivals
The Value of Prediction, and Cost of Success, in Drug HuntingMerck hands over $20M in IBD drug target deal with Flagship's QuotientThe N-of-1 Revolution in Personalized Medicine
- Merck, girding for Keytruda cliff, flies toward promising CML asset with $6.7B Terns acquisition- OrbiMed-backed Pinnacle adds $89M series B to power oral peptide pipeline- Sarepta's big bet on Arrowhead's siRNA assets yields early data





